Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03387020
Title Ribociclib and Everolimus in Treating Children With Recurrent or Refractory Malignant Brain Tumors
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Pediatric Brain Tumor Consortium
Indications
Therapies
Age Groups: child | adult
Covered Countries USA

Facility Status City State Zip Country Details
Children's Hospital Los Angeles Los Angeles California 90026 United States Details
Lucile Packard Children Hospital Stanford University Palo Alto California 94304 United States Details
Children's Hospital Colorado Aurora Colorado 80045 United States Details
Children's National Medical Center Washington District of Columbia 20010 United States Details
Children's Healthcare of Atlanta Atlanta Georgia 30322 United States Details
National Cancer Institute Pediatric Oncology Branch Bethesda Maryland 20892 United States Details
Memorial Sloan Kettering Cancer Center New York New York 10065 United States Details
Cincinnati Children Hospital Medical Center Cincinnati Ohio 45229 United States Details
Children Hospital of Pittsburgh of UPMC Pittsburgh Pennsylvania 15224 United States Details
Pediatric Brain Tumor Consortium Memphis Tennessee 38105 United States Details
St. Jude Children Research Hospital Memphis Tennessee 38105 United States Details
Texas Children's Cancer Center Houston Texas 77030 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field